Opendoor Surges as It’s Re-Added to Russell Indexes
Opendoor jumps after Russell 3000 return news; index buying, retail hype, and improving outlook lift the stock.
Already have an account? Sign in.
Opendoor jumps after Russell 3000 return news; index buying, retail hype, and improving outlook lift the stock.
Editas’ gene therapy EDIT-401 cut bad cholesterol ~90% in animals; analysts bullish; human trials expected in 2026.
Astrotech plans Moon mining for silicon, helium-3, metals, and water to support future AI and quantum computing tech.
Biohaven shares rose after strong early results from 2 drugs that quickly lower harmful antibodies in autoimmune diseases.